David Anderson, MD, on Systemic Tx vs Surgery for De Novo Stage IV Breast Cancer
David Anderson, MD, and Elisa Port, MD, discuss their findings on systemic Tx vs surgery for de novo stage IV breast cancer at the ASCO Annual Meeting.
David Anderson, MD, and Elisa Port, MD, discuss their findings on systemic Tx vs surgery for de novo stage IV breast cancer at the ASCO Annual Meeting.